First Time Loading...

E-Therapeutics PLC
LSE:ETX

Watchlist Manager
E-Therapeutics PLC Logo
E-Therapeutics PLC
LSE:ETX
Watchlist
Price: 9.4 GBX -3.59% Market Closed
Updated: May 4, 2024

E-Therapeutics PLC
Cash from Investing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

E-Therapeutics PLC
Cash from Investing Activities Peer Comparison

Comparables:
CNTA
AUTL
BCYC
IMCR
GNS

Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Investing Activities CAGR 3Y CAGR 5Y CAGR 10Y
E-Therapeutics PLC
LSE:ETX
Cash from Investing Activities
£15.3m
CAGR 3-Years
N/A
CAGR 5-Years
17%
CAGR 10-Years
21%
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
Cash from Investing Activities
-$127m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Autolus Therapeutics PLC
NASDAQ:AUTL
Cash from Investing Activities
-$11m
CAGR 3-Years
9%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bicycle Therapeutics PLC
NASDAQ:BCYC
Cash from Investing Activities
-$2.9m
CAGR 3-Years
-25%
CAGR 5-Years
-17%
CAGR 10-Years
N/A
Immunocore Holdings PLC
NASDAQ:IMCR
Cash from Investing Activities
-£5.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Genus PLC
LSE:GNS
Cash from Investing Activities
-£21.4m
CAGR 3-Years
11%
CAGR 5-Years
15%
CAGR 10-Years
6%

See Also

What is E-Therapeutics PLC's Cash from Investing Activities?
Cash from Investing Activities
15.3m GBP

Based on the financial report for Jan 31, 2023, E-Therapeutics PLC's Cash from Investing Activities amounts to 15.3m GBP.

What is E-Therapeutics PLC's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 10Y
21%